These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32216773)

  • 21. Disorders of "taste cognition" are associated with insular involvement in patients with Alzheimer's disease and vascular dementia: "memory of food is impaired in dementia and responsible for poor diet".
    Suto T; Meguro K; Nakatsuka M; Kato Y; Tezuka K; Yamaguchi S; Tashiro M
    Int Psychogeriatr; 2014 Jul; 26(7):1127-38. PubMed ID: 24697954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of subjective memory complaint and depressive symptoms with objective cognitive functions in prodromal Alzheimer's disease including pre-mild cognitive impairment.
    Seo EH; Kim H; Choi KY; Lee KH; Choo IH
    J Affect Disord; 2017 Aug; 217():24-28. PubMed ID: 28380342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-Analysis of Gene Expression Changes in the Blood of Patients with Mild Cognitive Impairment and Alzheimer's Disease Dementia.
    Bottero V; Potashkin JA
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. False-Positive Error Rates for Reliable Digit Span and Auditory Verbal Learning Test Performance Validity Measures in Amnestic Mild Cognitive Impairment and Early Alzheimer Disease.
    Loring DW; Goldstein FC; Chen C; Drane DL; Lah JJ; Zhao L; Larrabee GJ;
    Arch Clin Neuropsychol; 2016 Jun; 31(4):313-31. PubMed ID: 27084732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Systematic Review and Meta-Analysis of On-Road Simulator and Cognitive Driving Assessment in Alzheimer's Disease and Mild Cognitive Impairment.
    Hird MA; Egeto P; Fischer CE; Naglie G; Schweizer TA
    J Alzheimers Dis; 2016 May; 53(2):713-29. PubMed ID: 27176076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships Between Lower Olfaction and Brain White Matter Lesions in Elderly Subjects with Mild Cognitive Impairment.
    Heinrich J; Vidal JS; Simon A; Rigaud AS; Hanon O; Epelbaum J; Viollet C; Duron E
    J Alzheimers Dis; 2018; 61(3):1133-1141. PubMed ID: 29332036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K
    Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
    Iaccarino L; Chiotis K; Alongi P; Almkvist O; Wall A; Cerami C; Bettinardi V; Gianolli L; Nordberg A; Perani D
    J Alzheimers Dis; 2017; 59(2):603-614. PubMed ID: 28671117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical associations of anosognosia in mild cognitive impairment and Alzheimer's disease.
    Mak E; Chin R; Ng LT; Yeo D; Hameed S
    Int J Geriatr Psychiatry; 2015 Dec; 30(12):1207-14. PubMed ID: 25754519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severity of Depression Impacts Imminent Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    Defrancesco M; Marksteiner J; Kemmler G; Fleischhacker WW; Blasko I; Deisenhammer EA
    J Alzheimers Dis; 2017; 59(4):1439-1448. PubMed ID: 28731429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
    Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloid burden identifies neuropsychological phenotypes at increased risk of progression to Alzheimer's disease in mild cognitive impairment patients.
    Ciarmiello A; Tartaglione A; Giovannini E; Riondato M; Giovacchini G; Ferrando O; De Biasi M; Passera C; Carabelli E; Mannironi A; Foppiano F; Alfano B; Mansi L
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):288-296. PubMed ID: 30244387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. White Matter Degradation is Associated with Reduced Financial Capacity in Mild Cognitive Impairment and Alzheimer's Disease.
    Gerstenecker A; Hoagey DA; Marson DC; Kennedy KM
    J Alzheimers Dis; 2017; 60(2):537-547. PubMed ID: 28826185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease?
    Cecato JF; Martinelli JE; Izbicki R; Yassuda MS; Aprahamian I
    Int Psychogeriatr; 2016 May; 28(5):825-32. PubMed ID: 26620850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive decline and slower reaction time in elderly individuals with mild cognitive impairment.
    Chen KC; Weng CY; Hsiao S; Tsao WL; Koo M
    Psychogeriatrics; 2017 Nov; 17(6):364-370. PubMed ID: 28261945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Stogmann E; Moser D; Klug S; Gleiss A; Auff E; Dal-Bianco P; Pusswald G; Lehrner J
    J Alzheimers Dis; 2016; 49(4):1043-50. PubMed ID: 26577522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychological measures predict decline to Alzheimer's dementia from mild cognitive impairment.
    Summers MJ; Saunders NL
    Neuropsychology; 2012 Jul; 26(4):498-508. PubMed ID: 22612573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Verb Fluency in the Detection of Early Cognitive Impairment in Alzheimer's Disease.
    Alegret M; Peretó M; Pérez A; Valero S; Espinosa A; Ortega G; Hernández I; Mauleón A; Rosende-Roca M; Vargas L; Rodríguez-Gómez O; Abdelnour C; Berthier ML; Bak TH; Ruíz A; Tárraga L; Boada M
    J Alzheimers Dis; 2018; 62(2):611-619. PubMed ID: 29480180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.